17 alpha-hydroxyprogesterone caproate has been researched along with megestrol in 3 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (megestrol) | Trials (megestrol) | Recent Studies (post-2010) (megestrol) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 1,121 | 204 | 85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Decker, DG; Edmonson, JH; Jefferies, JA; Malkasian, GD; O'Brien, PC; Podratz, KC | 1 |
| Brockbank, E; Bryant, A; Gallagher, C; Kokka, F; Oram, D | 1 |
2 review(s) available for 17 alpha-hydroxyprogesterone caproate and megestrol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hormonal therapy in advanced or recurrent endometrial cancer.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Disease-Free Survival; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Neoplasm Staging; Progestins | 2010 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and megestrol
| Article | Year |
|---|---|
Effects of progestational agents in treatment of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Medrogestone; Megestrol; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Time Factors; Uterine Neoplasms | 1985 |